Advances in Immunopharmacology. Proceedings of the Third International Conference on Immunopharmacology, Florence, Italy, 6–9 May 1985

Content: 
Pergamon publications of related interest, Page ii
Front Matter, Page iii
Copyright, Page iv
From Natural Products Chemistry to Immunopharmacology, Pages 3-12, E. LEDERER
The Story of Bacterial Endotoxin, Pages 13-34, O. WESTPHAL, O. LÜDERITZ, Ch. GALANOS, H. MAYER, E.Th. RIETSCHEL
Experimental and Clinical Studies on the Antitumor and Antimicrobial Activities of Nocardial Cell Wall Skeleton and Muramyldipeptide Derivatives, Pages 35-43, Y. YAMAMURA
Current Status of the Immunotherapy and Biological Therapy of Cancer, Pages 47-54, E.M. HERSH
Immunotherapy of Acquired Immune Deficiency Syndrome (AIDS), AIDS-related Complex and Subjects at Risk, Pages 55-67, S. GUPTA
An Update on Interferon in Infectious Diseases, Pages 69-73, R.F. BETTS
Immunotherapy of Connective Tissue Disease, Pages 75-81, Y. SHIOKAWA, C. ABE
Hopes for Immunorestorative Therapy in Autoimmune Diseases, Pages 83-89, N. TALAL
The Biochemical Mechanism of Cellular Activation, Pages 93-99, F. HIRATA, K. MATSUDA, Y. WANO, T. HATTORI
Membrane Transport in the Messenger Function of Calcium (Ca), Pages 101-107, E. CARAFOLI
Stimulus Activation Coupling in Neutrophils, Pages 109-113, T. POZZAN, F. DI VIRGILIO, S. TREVES, D. MILANI, D.P. LEW
Mechanisms of Arachidonic Acid Turnover Implicated in Cell Activation, Pages 115-126, K. RESCH, M. GOPPELT, G.M. HÄNSCH, C.-F. KÖRNER, M. MARTIN, M. SZAMEL
Release of Prostaglandins and Modulation of Leukocyte Functions, Pages 127-136, D. GEMSA, M. NAIN, G.M. HÄNSCH, D. LOVETT, P.H. KRAMMER, K. RESCH
Human Tumor Necrosis Factor (LuKII): Recent Developments, Pages 139-148, B.Y. RUBIN, S.L. ANDERSON, S.A. SULLIVAN, A. PINTER, B.D. WILLIAMSON, E.A. CARSWELL, L.J. OLD
Factors from T Suppressor Cells: Current Status and Perspectives, Pages 149-151, D.R. WEBB, J.A. KAPP, K. KRUPEN, C.W. PIERCE, C.M. SORENSEN, C.W. TURCK
T Cell Factors Involved in the Regulation of the IgE Antibody Response, Pages 153-160, K. ISHIZAKA
T Cell-derived Immunoglobulin-Binding Factors (IBF): Molecular Heterogeneity and Inhibition of Ig Synthesis by B Cell Hybridomas, Pages 161-168, W.H. FRIDMAN, J-L. TEILLAUD, M. DAËRON, U. BLANK, S. AMIGORENA, J. MONCUIT, A. GALINHA, C. NÉAUPORT-SAUTÈS
The Initial Events in Leukocytic Stimulation, Pages 171-176, C.G. COCHRANE
Role of Eicosanoids in Lymphocyte Activation: A Review, Pages 177-188, J.M. BAILEY, R. COFFEY, W.D. MERRITT, J. HADDEN
Mechanisms and Pharmacology of NK Cell Activity, Pages 189-192, R.B. HERBERMAN
Mechanisms of Neutrophil Activation: Phosphoinositides, Protein Kinase C and Calcium Movements, Pages 193-200, H.M. KORCHAK, K. VIENNE, C. WILKENFELD, C. ROBERTS, A.M. RICH, G. WEISSMANN
Biochemical Events Involved in IgE-Mediated Mast Cell Activation for Mediator Release, Pages 201-209, T. ISHIZAKA, J.R. WHITE
Regulation of the 5-Lipoxygenase Pathway of Arachidonic Acid Metabolism by N-3 Fatty Acids, Pages 211-216, R.A. LEWIS, K.F. AUSTEN
Interleukin 1 Mediated in Vitro Antitumor Activities, Pages 219-222, J.J. OPPENHEIM, K. MATSUSHIMA, K. ONOZAKI
The Biological Activities of Human Interleukin-1: Purified and Recombinant Materials, Pages 223-230, C.A. DINARELLO
New Strategies of Immunotherapy, Pages 231-236, J.W. HADDEN
Immunological Properties of Ciclosporin (Sandimmune®), Pages 239-250, J-F. BOREL
Cellular Requirements and Mechanisms of Action of Antigen-specific Suppressor T Cell Factors, Pages 251-256, C.W. PIERCE, M.T. LOPEZ, C.M. SORENSEN, J.A. KAPP
Immunomodulation by Anticancer Compounds, Pages 257-265, E. MIHICH, M.J. EHRKE
Modulation of Immunity by Xenobiotics, Pages 267-275, J.H. DEAN, L.D. LAUER, R.V. HOUSE, F. SPREAFICO
Perspectives in the Management of Allergic and Pseudo-Allergic Reactions, Pages 277-282, A.L. DE WECK
Tumour Inhibitory Properties of Monoclonal Antibody 791T/36 — Drug Conjugates, Pages 285-292, R.W. BALDWIN
Treatment of Malignant Melanoma with a Mouse Monoclonal IgG3 Antibody Detecting the Ganglioside GD3, Pages 293-296, A.N. HOUGHTON, C. CORDON-CARDO, S. WELT, H.F. OETTGEN, L.J. OLD
Immunotoxins, Pages 297-302, E.S. VITETTA
Monoclonal Antibodies as Diagnostic and Therapeutic Cardiovascular Agents, Pages 303-307, E. HABER, G.R. MATSUEDA
Novel Antibodies by DNA Transfection, Pages 309-314, M.S. NEUBERGER
Prediction of Biologically Active Epitopes for Synthetic Vaccines, Pages 317-327, J.L. BITTLE
Use of Muramyl Peptides in Synthetic and Semisynthetic Vaccines, Pages 329-336, L. CHEDID
Design of Hepatitis B Vaccines, Pages 337-345, A.R. NEURATH, S.B.H. KENT, N. STRICK
Synthetic Peptides as the Basis for Future Vaccines. Application in the Influenza and Cholera Toxin Systems, Pages 347-355, R. ARNON
Sporozoite Malaria Vaccines, Pages 357-361, W.T. HOCKMEYER, W.R. BALLOU, J.F. YOUNG
Bacteria, Bacterial Fractions and Products as Immunomodulators I, Pages 365-368, G. MATHÉ, S. KOTANI
Glucans as Immunomodulators, Pages 369-375, N.R. DI LUZIO, P. JACQUES
Mediators and Mechanisms I, Pages 377-378, J.E. ALOUF, A.S. ROSENTHAL
Thymic Hormones, Pages 379-380, N. TRAININ, A.L. GOLDSTEIN
Synthetic Immunomodifiers, Pages 381-388, M.A. CHIRIGOS, J. WYBRAN
Interactions between the Neuroendocrine and Immune Systems, Pages 389-393, K. MAŠEK, E. SORKIN
Interferons and Inducers, Pages 395-396, A. TAGLIABUE, W.E. STEWART
Glucans as Immunomodifiers II, Pages 397-402, G. CHIHARA, E. MIHICH
Synthetic Immunomodifiers II, Pages 403-406, G. RENOUX, J.E. TALMADGE
Mediators and Mechanisms, Pages 407-408, K.L. MELMON, J-P. GIROUD
MDP and Derivatives I, Pages 409-413, I. AZUMA, M. PARANT
Thymic Hormones II, Pages 415-418, M. GHIONE, J-L. TOURAINE
Bacteria, Bacterial Fractions and Products as Immunopotentiators II, Pages 419-422, T. HOSHINO, M. MICKSCHE
Other Immunomodifiers from Natural Sources, Pages 423-424, A. NICOLIN, P. PERITI
Immunodepressive Agents, Pages 425-427, F. DAMMACCO, P.A. MIESCHER
Bacteria, Bacterial Fractions and Products as Immunomodulators III, Pages 429-430, J-L. TOURAINE, A.G. JOHNSON
Immunotoxicology, Pages 431-437, J.G. BEKESI, J.H. DEAN
Cyclization Products of Phenylthiourea Compounds in Adulterated Rapeseed Oil as possible Aetiological Factor in Spanish Toxic Oil Syndrome, Pages 439-442, M.E. KAMMÜLLER, A.H. PENNINKS, W. SEINEN
TCDF Induced Alterations of IL-1 Responsiveness and Production in Adult or Perinatal Treated Mice, Pages 443-444, A. VECCHI, M. SIRONI, E. SFREDDO-GALLOTTA, S. BERNASCONI
Thymocytes as Target of Dialkyltin Toxicity, Pages 445-447, A.H. PENNINKS, N.J. SNOEIJ, W. SEINEN
The Popliteal Lymph Node Assay: A Test System for Chemically Induced Autoimmune and Allergic Reactions, Pages 449-451, M.E. KAMMÜLLER, A.H. PENNINKS, W. SEINEN
Differential Sensitivity to 3-Methylcholanthrene (3MC) Induced Immunosuppression in Young and Old Mice, Pages 453-454, M. SIRONI, E. SFREDDO-GALLOTTA, A. GRAZIANI, M.C. SALETTI, L. CANTONI, A. VECCHI
Anti-Allergic Agents — Summary, Pages 455-457, M. RICCI
Pharmacology of Macrophages and Related Cells, Pages 459-460, R.M. FAUVE, C. RICCARDI
Synthetic Immunostimulants III, Pages 461-464, F. SPREAFICO, D. TRIZIO
Immunopharmacology of Inflammation, Pages 465-468, D.A. WILLOUGHBY, G. MARONE
Novel Vaccines, Pages 469-474, F. AUDIBERT, E.H. BEACHEY
Monoclonal Antibodies as Pharmacological Agents, Pages 475-476, G. GOLDSTEIN, F.K. JANSEN
Novel Approaches in Immune Manipulation, Pages 477-478, A. Mantovani, A. Biondi
MDP and Derivatives II, Pages 479-485, A.C. ALLISON, E.D. WACHSMUTH
Thymic Hormones, Interleukins, Endotoxin and Thymomimetic Drugs in T Lymphocyte Ontogeny, Pages 487-497, J.W. HADDEN, S. SPECTER, A. GALY, J-L. TOURAINE, E.M. HADDEN
Author Index, Pages 499-500
Subject Index, Pages 501-503